Search Within

David R D'Adamo

  1. "Gastrointestinal Oncology Service"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Center for Pancreatic Cancer Research (7)
  2. Department of Medicine (7)
  3. Gastrointestinal Oncology Service (7)
  4. Solid Tumor Oncology Division (7)
  5. Population Sciences Research Program (4)
  6. Clinical Genetics Service (3)

More Groups

People
  1. David Kelsen (6)
  2. Eileen O'Reilly (5)
  3. David Ilson (3)
  4. Emmy Ludwig (3)
  5. Erin Salo-Mullen (3)
  6. Gary Schwartz (3)

More People

Years
  1. 2011 (2)
  2. 2010 (1)
  3. 2006 (3)
  4. 2005 (1)
Publications
  1. Journal of Clinical Oncology (6)
  2. The Oncologist (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. Oxford University Press (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes in pancreatic adenocarcinoma (PAC) associated with a known BRCA mutation
    Meeting Abstract

    Lowery, M. A.; Stadler, Z. K.; Ludwig, E.; Salo-Mullen, E.; D'Adamo, D. R.; Allen, P. J.; Kurtz, R. C.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • An emerging entity: Pancreatic adenocarcinoma associated with a known brca mutation: Clinical descriptors, treatment implications, and future directions
    Journal Article

    Lowery, M. A.; Kelsen, D. P.; Stadler, Z. K.; Yu, K. H.; Janjigian, Y. Y.; Ludwig, E.; D'adamo, D. R.; Salo-Mullen, E.; Robson, M. E.; Allen, P. J.; more...
    The Oncologist (2011)

    Fulltext@MSK | Save
  • Clinical outcomes in pancreatic adenocarcinoma (PAC) in breast cancer (BC) survivors
    Meeting Abstract

    Lowery, M. A.; Stadler, Z. K.; Ludwig Miller, E.; D'Adamo, D. R.; Salo-Mullen, E.; Allen, P.; Kurtz, R. C.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Final results of a multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with metastatic gastric or gastroesophageal (GEJ) adenocarcinoma (NCI #6447)
    Meeting Abstract

    Shah, M. A.; Ramanathan, R. K.; Ilson, D.; Randazzo, J.; Schwartz, G. K.; Tse, A.; D'adamo, D.; Levner, A.; Capanu, M.; Kelsen, D. P.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Phase I trial of preoperative cetuximab with concurrent continuous infusion 5-fluorouracil and pelvic radiation in patients with local-regionally advanced rectal cancer
    Meeting Abstract

    Chung, K. Y.; Minsky, B.; Schrag, D.; O'reilly, E.; D'adamo, D.; Hollywood, E.; Quinones, M.; Saltz, L.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna
    Journal Article

    Shah, M. A.; Ramanathan, R. K.; Ilson, D. H.; Levnor, A.; D'adamo, D.; O'reilly, E.; Tse, A.; Trocola, R.; Schwartz, L.; Capanu, M.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Meeting Abstract

    Shah, M. A.; Ilson, D.; Ramanathan, R. K.; Levner, A.; D'adamo, D.; Schwartz, L.; Casper, E.; Schwartz, G. K.; Kelsen, D. P.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save